Stock Quote. NASDAQ: TENX. $3.53. -0.02. -0.56%. View Stock Chart. IR cONTACT. John Fraunces Managing Director Investor Relations Corporate Communications C: ( ...
Investor Relations. We are a life science technology company building products to interrogate, understand and master biology.
Tenax Therapeutics Inc (NASDAQ:TENX). Tenax ... Stern Investor Relations 212.362.1200 jesse ... Investor Contacts · Tearsheet · Email Alerts · Media · Press ...
IR Contact. Contact us by email at ... 10x Genomics to send you the requested Investor Email Alert updates. * ... Events & Presentations. Quarterly Reports. Annual ...
A Phase 3, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet ...
People also ask
Is Tenax Therapeutics a good stock to buy?
What does Tenax Therapeutics do?
As the leading end-to-end transaction platform, Ten-X offers buyers access to new opportunities and a simplified transaction. FIND YOUR INVESTMENT. For Sellers.
Missing: relations | Show results with:relations
Tenax Therapeutics Inc (NASDAQ:TENX). Tenax ... Investor Relations. LifeSci Advisors, John Mullaly ... Investor Contacts · Tearsheet · Email Alerts · Media · Press ...